nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—coronary artery disease—metabolic syndrome X	0.366	0.627	CtDrD
Lisinopril—ACE—metabolic syndrome X	0.306	1	CbGaD
Lisinopril—hypertension—metabolic syndrome X	0.218	0.374	CtDrD
Lisinopril—ACE—arteriole—metabolic syndrome X	0.00858	0.202	CbGeAlD
Lisinopril—ACE—tunica intima—metabolic syndrome X	0.00609	0.143	CbGeAlD
Lisinopril—ACE—sympathetic nervous system—metabolic syndrome X	0.00547	0.128	CbGeAlD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—metabolic syndrome X	0.00373	0.107	CbGpPWpGaD
Lisinopril—ACE—autonomic nervous system—metabolic syndrome X	0.00367	0.0863	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—metabolic syndrome X	0.00355	0.102	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—AGT—metabolic syndrome X	0.00237	0.0677	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGT—metabolic syndrome X	0.00225	0.0645	CbGpPWpGaD
Lisinopril—ACE2—cardiovascular system—metabolic syndrome X	0.00221	0.052	CbGeAlD
Lisinopril—ACE2—kidney—metabolic syndrome X	0.00217	0.0509	CbGeAlD
Lisinopril—ACE—artery—metabolic syndrome X	0.00208	0.0489	CbGeAlD
Lisinopril—ACE2—adipose tissue—metabolic syndrome X	0.00195	0.0459	CbGeAlD
Lisinopril—ACE—endothelium—metabolic syndrome X	0.00176	0.0413	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—PLA2G7—metabolic syndrome X	0.00173	0.0496	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—NOS3—metabolic syndrome X	0.00165	0.0473	CbGpPWpGaD
Lisinopril—ACE—blood vessel—metabolic syndrome X	0.00162	0.0381	CbGeAlD
Lisinopril—Appetite absent—Metformin—metabolic syndrome X	0.00149	0.0491	CcSEcCtD
Lisinopril—Azotaemia—Metformin—metabolic syndrome X	0.00139	0.0458	CcSEcCtD
Lisinopril—ACE2—liver—metabolic syndrome X	0.00137	0.0322	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—TGFB1—metabolic syndrome X	0.00109	0.0313	CbGpPWpGaD
Lisinopril—Heartburn—Metformin—metabolic syndrome X	0.00108	0.0355	CcSEcCtD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—metabolic syndrome X	0.00106	0.0302	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—GHRL—metabolic syndrome X	0.00101	0.029	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—AGT—metabolic syndrome X	0.00101	0.0288	CbGpPWpGaD
Lisinopril—SLC15A1—kidney—metabolic syndrome X	0.000988	0.0232	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—metabolic syndrome X	0.000981	0.0281	CbGpPWpGaD
Lisinopril—Rhinorrhoea—Metformin—metabolic syndrome X	0.000914	0.0301	CcSEcCtD
Lisinopril—Accidental injury—Metformin—metabolic syndrome X	0.000837	0.0276	CcSEcCtD
Lisinopril—Chest discomfort—Metformin—metabolic syndrome X	0.000837	0.0276	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—PLA2G7—metabolic syndrome X	0.000775	0.0222	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—NOS3—metabolic syndrome X	0.000739	0.0211	CbGpPWpGaD
Lisinopril—ACE—cardiovascular system—metabolic syndrome X	0.000724	0.017	CbGeAlD
Lisinopril—ACE—kidney—metabolic syndrome X	0.000708	0.0166	CbGeAlD
Lisinopril—Neuropathy—Metformin—metabolic syndrome X	0.000695	0.0229	CcSEcCtD
Lisinopril—Lightheadedness—Metformin—metabolic syndrome X	0.000662	0.0219	CcSEcCtD
Lisinopril—ACE—adipose tissue—metabolic syndrome X	0.000639	0.015	CbGeAlD
Lisinopril—SLC15A1—liver—metabolic syndrome X	0.000625	0.0147	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—GALNT2—metabolic syndrome X	0.000623	0.0178	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—AGT—metabolic syndrome X	0.000622	0.0178	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—LEP—metabolic syndrome X	0.000609	0.0174	CbGpPWpGaD
Lisinopril—Nasal congestion—Metformin—metabolic syndrome X	0.00059	0.0195	CcSEcCtD
Lisinopril—Injury—Metformin—metabolic syndrome X	0.000585	0.0193	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—TOMM40—metabolic syndrome X	0.00058	0.0166	CbGpPWpGaD
Lisinopril—ABCB1—blood vessel—metabolic syndrome X	0.000571	0.0134	CbGeAlD
Lisinopril—Renal impairment—Metformin—metabolic syndrome X	0.000565	0.0186	CcSEcCtD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.000559	0.016	CbGpPWpGaD
Lisinopril—Hypoglycaemia—Metformin—metabolic syndrome X	0.000551	0.0182	CcSEcCtD
Lisinopril—Pain in extremity—Metformin—metabolic syndrome X	0.000537	0.0177	CcSEcCtD
Lisinopril—ACE2—Peptide hormone metabolism—INS—metabolic syndrome X	0.00052	0.0149	CbGpPWpGaD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.000511	0.0146	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—IGF1—metabolic syndrome X	0.000503	0.0144	CbGpPWpGaD
Lisinopril—Dehydration—Metformin—metabolic syndrome X	0.0005	0.0165	CcSEcCtD
Lisinopril—ACE—ACE Inhibitor Pathway—TGFB1—metabolic syndrome X	0.000488	0.014	CbGpPWpGaD
Lisinopril—Breast disorder—Metformin—metabolic syndrome X	0.000486	0.016	CcSEcCtD
Lisinopril—Cramp muscle—Metformin—metabolic syndrome X	0.000484	0.016	CcSEcCtD
Lisinopril—Nasopharyngitis—Metformin—metabolic syndrome X	0.000481	0.0159	CcSEcCtD
Lisinopril—Influenza—Metformin—metabolic syndrome X	0.000464	0.0153	CcSEcCtD
Lisinopril—Pancreatitis—Metformin—metabolic syndrome X	0.000455	0.015	CcSEcCtD
Lisinopril—Angina pectoris—Metformin—metabolic syndrome X	0.000452	0.0149	CcSEcCtD
Lisinopril—Sweating increased—Metformin—metabolic syndrome X	0.000452	0.0149	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—GHRL—metabolic syndrome X	0.000452	0.0129	CbGpPWpGaD
Lisinopril—ACE—liver—metabolic syndrome X	0.000448	0.0105	CbGeAlD
Lisinopril—Fosinopril—ACE—metabolic syndrome X	0.000441	0.141	CrCbGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.000439	0.0125	CbGpPWpGaD
Lisinopril—Neutropenia—Metformin—metabolic syndrome X	0.000434	0.0143	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000432	0.0142	CcSEcCtD
Lisinopril—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000406	0.0134	CcSEcCtD
Lisinopril—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000392	0.0129	CcSEcCtD
Lisinopril—Bradycardia—Metformin—metabolic syndrome X	0.000378	0.0125	CcSEcCtD
Lisinopril—Rhinitis—Metformin—metabolic syndrome X	0.000373	0.0123	CcSEcCtD
Lisinopril—Hepatitis—Metformin—metabolic syndrome X	0.000372	0.0123	CcSEcCtD
Lisinopril—Oedema peripheral—Metformin—metabolic syndrome X	0.000366	0.0121	CcSEcCtD
Lisinopril—Spirapril—ACE—metabolic syndrome X	0.000356	0.114	CrCbGaD
Lisinopril—Flushing—Metformin—metabolic syndrome X	0.000345	0.0114	CcSEcCtD
Lisinopril—Moexipril—ACE—metabolic syndrome X	0.000341	0.109	CrCbGaD
Lisinopril—Angiopathy—Metformin—metabolic syndrome X	0.000337	0.0111	CcSEcCtD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000337	0.00964	CbGpPWpGaD
Lisinopril—Mediastinal disorder—Metformin—metabolic syndrome X	0.000335	0.0111	CcSEcCtD
Lisinopril—Chills—Metformin—metabolic syndrome X	0.000334	0.011	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—PLA2G7—metabolic syndrome X	0.000327	0.00937	CbGpPWpGaD
Lisinopril—Erythema—Metformin—metabolic syndrome X	0.000324	0.0107	CcSEcCtD
Lisinopril—Malnutrition—Metformin—metabolic syndrome X	0.000324	0.0107	CcSEcCtD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000321	0.00918	CbGpPWpGaD
Lisinopril—Flatulence—Metformin—metabolic syndrome X	0.000319	0.0105	CcSEcCtD
Lisinopril—Quinapril—ACE—metabolic syndrome X	0.000317	0.101	CrCbGaD
Lisinopril—Cilazapril—ACE—metabolic syndrome X	0.000317	0.101	CrCbGaD
Lisinopril—Dysgeusia—Metformin—metabolic syndrome X	0.000317	0.0105	CcSEcCtD
Lisinopril—Muscle spasms—Metformin—metabolic syndrome X	0.000311	0.0103	CcSEcCtD
Lisinopril—Trandolapril—ACE—metabolic syndrome X	0.000307	0.098	CrCbGaD
Lisinopril—Ramipril—ACE—metabolic syndrome X	0.000307	0.098	CrCbGaD
Lisinopril—Vision blurred—Metformin—metabolic syndrome X	0.000305	0.0101	CcSEcCtD
Lisinopril—Tremor—Metformin—metabolic syndrome X	0.000303	0.01	CcSEcCtD
Lisinopril—Ill-defined disorder—Metformin—metabolic syndrome X	0.0003	0.00991	CcSEcCtD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000294	0.0084	CbGpPWpGaD
Lisinopril—Malaise—Metformin—metabolic syndrome X	0.000292	0.00963	CcSEcCtD
Lisinopril—Syncope—Metformin—metabolic syndrome X	0.00029	0.00958	CcSEcCtD
Lisinopril—Palpitations—Metformin—metabolic syndrome X	0.000286	0.00944	CcSEcCtD
Lisinopril—Loss of consciousness—Metformin—metabolic syndrome X	0.000284	0.00938	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—GALNT2—metabolic syndrome X	0.000278	0.00797	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—AGT—metabolic syndrome X	0.000278	0.00795	CbGpPWpGaD
Lisinopril—Benazepril—ACE—metabolic syndrome X	0.000276	0.088	CrCbGaD
Lisinopril—Chest pain—Metformin—metabolic syndrome X	0.000276	0.00909	CcSEcCtD
Lisinopril—Myalgia—Metformin—metabolic syndrome X	0.000276	0.00909	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000274	0.00903	CcSEcCtD
Lisinopril—Discomfort—Metformin—metabolic syndrome X	0.000272	0.00898	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—LEP—metabolic syndrome X	0.000272	0.00779	CbGpPWpGaD
Lisinopril—Oedema—Metformin—metabolic syndrome X	0.000264	0.00871	CcSEcCtD
Lisinopril—Infection—Metformin—metabolic syndrome X	0.000262	0.00866	CcSEcCtD
Lisinopril—Shock—Metformin—metabolic syndrome X	0.00026	0.00857	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—TOMM40—metabolic syndrome X	0.000259	0.00741	CbGpPWpGaD
Lisinopril—Thrombocytopenia—Metformin—metabolic syndrome X	0.000259	0.00853	CcSEcCtD
Lisinopril—Skin disorder—Metformin—metabolic syndrome X	0.000257	0.00846	CcSEcCtD
Lisinopril—Hyperhidrosis—Metformin—metabolic syndrome X	0.000255	0.00842	CcSEcCtD
Lisinopril—ABCB1—cardiovascular system—metabolic syndrome X	0.000255	0.00599	CbGeAlD
Lisinopril—Anorexia—Metformin—metabolic syndrome X	0.000252	0.00831	CcSEcCtD
Lisinopril—ABCB1—kidney—metabolic syndrome X	0.000249	0.00586	CbGeAlD
Lisinopril—Hypotension—Metformin—metabolic syndrome X	0.000247	0.00814	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000241	0.00794	CcSEcCtD
Lisinopril—Paraesthesia—Metformin—metabolic syndrome X	0.000237	0.00782	CcSEcCtD
Lisinopril—Dyspnoea—Metformin—metabolic syndrome X	0.000235	0.00777	CcSEcCtD
Lisinopril—Somnolence—Metformin—metabolic syndrome X	0.000235	0.00775	CcSEcCtD
Lisinopril—Enalapril—ACE—metabolic syndrome X	0.000233	0.0743	CrCbGaD
Lisinopril—Dyspepsia—Metformin—metabolic syndrome X	0.000232	0.00767	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—INS—metabolic syndrome X	0.000232	0.00665	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—G6PC2—metabolic syndrome X	0.000231	0.00662	CbGpPWpGaD
Lisinopril—Decreased appetite—Metformin—metabolic syndrome X	0.00023	0.00758	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000228	0.00752	CcSEcCtD
Lisinopril—Fatigue—Metformin—metabolic syndrome X	0.000228	0.00751	CcSEcCtD
Lisinopril—Constipation—Metformin—metabolic syndrome X	0.000226	0.00745	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—IGF1—metabolic syndrome X	0.000225	0.00643	CbGpPWpGaD
Lisinopril—ABCB1—adipose tissue—metabolic syndrome X	0.000225	0.00528	CbGeAlD
Lisinopril—Feeling abnormal—Metformin—metabolic syndrome X	0.000218	0.00718	CcSEcCtD
Lisinopril—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000216	0.00713	CcSEcCtD
Lisinopril—Urticaria—Metformin—metabolic syndrome X	0.00021	0.00692	CcSEcCtD
Lisinopril—Abdominal pain—Metformin—metabolic syndrome X	0.000209	0.00689	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—GHRL—metabolic syndrome X	0.000191	0.00547	CbGpPWpGaD
Lisinopril—Asthenia—Metformin—metabolic syndrome X	0.000189	0.00625	CcSEcCtD
Lisinopril—Pruritus—Metformin—metabolic syndrome X	0.000187	0.00617	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—ACE—metabolic syndrome X	0.000185	0.0053	CbGpPWpGaD
Lisinopril—Diarrhoea—Metformin—metabolic syndrome X	0.000181	0.00596	CcSEcCtD
Lisinopril—Dizziness—Metformin—metabolic syndrome X	0.000175	0.00576	CcSEcCtD
Lisinopril—Nateglinide—PPARG—metabolic syndrome X	0.000173	0.0552	CrCbGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000169	0.00482	CbGpPWpGaD
Lisinopril—Vomiting—Metformin—metabolic syndrome X	0.000168	0.00554	CcSEcCtD
Lisinopril—Rash—Metformin—metabolic syndrome X	0.000167	0.00549	CcSEcCtD
Lisinopril—Dermatitis—Metformin—metabolic syndrome X	0.000166	0.00549	CcSEcCtD
Lisinopril—Headache—Metformin—metabolic syndrome X	0.000165	0.00546	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	0.000159	0.00454	CbGpPWpGaD
Lisinopril—ABCB1—liver—metabolic syndrome X	0.000158	0.0037	CbGeAlD
Lisinopril—Nausea—Metformin—metabolic syndrome X	0.000157	0.00518	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—IGF2—metabolic syndrome X	0.000148	0.00424	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PLA2G7—metabolic syndrome X	0.000146	0.00419	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—GCK—metabolic syndrome X	0.000128	0.00365	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	0.000126	0.0036	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000118	0.00336	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—AGT—metabolic syndrome X	0.000117	0.00336	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000117	0.00334	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—LEP—metabolic syndrome X	0.000115	0.00329	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	0.000105	0.003	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—INS—metabolic syndrome X	9.83e-05	0.00281	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	9.8e-05	0.0028	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CCL2—metabolic syndrome X	9.67e-05	0.00277	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	9.66e-05	0.00276	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF1—metabolic syndrome X	9.5e-05	0.00272	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GHRL—metabolic syndrome X	8.54e-05	0.00244	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	8.06e-05	0.00231	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGF2—metabolic syndrome X	6.61e-05	0.00189	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—metabolic syndrome X	6.52e-05	0.00187	CbGpPWpGaD
Lisinopril—Nateglinide—ALB—metabolic syndrome X	6.51e-05	0.0208	CrCbGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	6.4e-05	0.00183	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	6.18e-05	0.00177	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—AGT—metabolic syndrome X	5.24e-05	0.0015	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—LEP—metabolic syndrome X	5.14e-05	0.00147	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—metabolic syndrome X	5.12e-05	0.00146	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	5.05e-05	0.00144	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	4.98e-05	0.00142	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—INS—metabolic syndrome X	4.39e-05	0.00126	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CCL2—metabolic syndrome X	4.32e-05	0.00124	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGF1—metabolic syndrome X	4.24e-05	0.00121	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	4.09e-05	0.00117	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	3.97e-05	0.00114	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	3.53e-05	0.00101	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	3.45e-05	0.000987	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	3.39e-05	0.00097	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	3.24e-05	0.000926	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	2.8e-05	0.000801	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	2.72e-05	0.000779	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	2.61e-05	0.000748	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	2.56e-05	0.000734	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	2.3e-05	0.000659	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	2.25e-05	0.000643	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FMO3—metabolic syndrome X	2.22e-05	0.000636	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	2.16e-05	0.000619	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	2.09e-05	0.000597	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—EPHX2—metabolic syndrome X	1.98e-05	0.000567	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	1.98e-05	0.000567	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	1.91e-05	0.000547	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—G6PC2—metabolic syndrome X	1.86e-05	0.000533	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	1.68e-05	0.000482	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FABP4—metabolic syndrome X	1.58e-05	0.000453	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	1.5e-05	0.000429	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	1.38e-05	0.000396	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	1.38e-05	0.000395	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—G6PD—metabolic syndrome X	1.34e-05	0.000383	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HDAC3—metabolic syndrome X	1.31e-05	0.000374	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	1.29e-05	0.000369	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCKR—metabolic syndrome X	1.28e-05	0.000365	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPA—metabolic syndrome X	1.28e-05	0.000365	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	1.24e-05	0.000354	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA5—metabolic syndrome X	1.22e-05	0.00035	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.17e-05	0.000334	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TRIB3—metabolic syndrome X	1.14e-05	0.000325	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.09e-05	0.000313	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAMPT—metabolic syndrome X	1.02e-05	0.000292	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LIPC—metabolic syndrome X	1.01e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCK—metabolic syndrome X	1.01e-05	0.00029	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOC3—metabolic syndrome X	1.01e-05	0.000288	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CETP—metabolic syndrome X	9.78e-06	0.00028	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	9.6e-06	0.000275	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SCARB1—metabolic syndrome X	9.36e-06	0.000268	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SREBF1—metabolic syndrome X	9.09e-06	0.00026	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMGCR—metabolic syndrome X	8.84e-06	0.000253	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GOT2—metabolic syndrome X	8.84e-06	0.000253	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	8.67e-06	0.000248	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCA1—metabolic syndrome X	7.88e-06	0.000226	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	7.88e-06	0.000226	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GGT1—metabolic syndrome X	7.63e-06	0.000218	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GOT1—metabolic syndrome X	7.63e-06	0.000218	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOB—metabolic syndrome X	6.48e-06	0.000185	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	6.3e-06	0.00018	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPL—metabolic syndrome X	6.19e-06	0.000177	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CD36—metabolic syndrome X	5.88e-06	0.000168	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARA—metabolic syndrome X	5.46e-06	0.000156	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AGT—metabolic syndrome X	5.29e-06	0.000151	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOE—metabolic syndrome X	5.18e-06	0.000148	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA1—metabolic syndrome X	5.13e-06	0.000147	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—metabolic syndrome X	4.52e-06	0.000129	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—INS—metabolic syndrome X	4.43e-06	0.000127	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—metabolic syndrome X	4.06e-06	0.000116	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.88e-06	0.000111	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.55e-06	0.000102	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.79e-06	5.11e-05	CbGpPWpGaD
